Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study
Randomized controlled trials have shown that dexamphetamine sulfate (DEX) is efficacious in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents; however, data on the effectiveness and safety of DEX in routine practice are scarce.
Main Authors: | Uebel-von Sandersleben Henrik, Dangel Oliver, Fischer Roland, Ruhmann Michaela, Huss Michael |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-01-01
|
Series: | Scandinavian Journal of Child and Adolescent Psychiatry and Psychology |
Subjects: | |
Online Access: | https://doi.org/10.21307/sjcapp-2021-009 |
Similar Items
-
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition Effects
by: Sandersleben Henrik Uebel-von, et al.
Published: (2023-11-01) -
ADHD in adults in a nutshell
by: Ewa Rzeska, et al.
Published: (2024-01-01) -
Diagnosis and management of ADHD: a pediatric perspective on practice and challenges in Switzerland
by: A. Zysset, et al.
Published: (2023-03-01) -
Obstetric complications in mothers with ADHD
by: Caroline J. Walsh, et al.
Published: (2022-11-01) -
Adult ADHD in the Republic of Ireland: the evolving response
by: Shaeraine Raaj, et al.